Whitehawk Therapeutics (WHWK) Notes Payables (2010 - 2020)
Whitehawk Therapeutics (WHWK) reported Notes Payables of $9.0 million for Q4 2020, down 27.11% on a QoQ basis from $12.4 million in Q4 2016.
Whitehawk Therapeutics (WHWK) has 8 years of Notes Payables data on file, last reported at $9.0 million in Q4 2020.
- Quarterly Notes Payables changed N/A year-over-year to $9.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $9.0 million (changed N/A YoY) and the FY2020 annual result came in at $9.0 million, changed N/A from the prior year.
- Notes Payables declined to $9.0 million in Q4 2020 per WHWK's latest filing, from $12.4 million in the prior quarter.
- Across five years, Notes Payables topped out at $12.4 million in Q4 2016 and bottomed at $160000.0 in Q1 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 9.03 Mn |
| Dec 31, 2016 | 12.39 Mn |
| Sep 30, 2016 | 170,000.00 |
| Jun 30, 2016 | 170,000.00 |
| Mar 31, 2016 | 160,000.00 |
| Dec 31, 2015 | 160,000.00 |
| Sep 30, 2015 | 145,000.00 |
| Jun 30, 2015 | 145,000.00 |
| Mar 31, 2015 | 145,000.00 |
| Dec 31, 2014 | 125,000.00 |
| Sep 30, 2014 | 125,000.00 |
| Jun 30, 2014 | 110,000.00 |
| Mar 31, 2014 | 110,000.00 |
| Dec 31, 2013 | 110,000.00 |
| Sep 30, 2013 | 110,000.00 |
| Jun 30, 2013 | 110,000.00 |
| Mar 31, 2013 | 85,000.00 |
| Dec 31, 2012 | 85,000.00 |
| Sep 30, 2012 | 85,000.00 |
| Jun 30, 2012 | 85,000.00 |
| Mar 31, 2012 | 85,000.00 |
| Dec 31, 2011 | 60,000.00 |
| Sep 30, 2011 | 60,000.00 |
| Jun 30, 2011 | 60,000.00 |
| Dec 31, 2010 | 60,000.00 |